Functional mapping of androgen receptor enhancer activity
暂无分享,去创建一个
H. G. van der Poel | Faraz Hach | C. Collins | M. Gleave | B. McConeghy | W. Zwart | F. Feng | E. Emberly | M. Hoogstraat | A. Bergman | C. Huang | Shreyas Lingadahalli | Tunc Morova | Dogancan Ozturan | Eugene Hu | Ivan Pak Lok Yu | S. Linder | S. Stelloo | Funda Sar | Umut Berkay Altintas | Mohammadali Saffarzadeh | S. L. Bihan | Bengul Gokbayrak | N. Lack | Ivan Pak Lok Yu | Stephane Le Bihan | C. F. Huang | Umut Berkay Altıntaş | F. Sar
[1] Faraz Hach,et al. Functional mapping of androgen receptor enhancer activity , 2021, Genome Biology.
[2] Howard Y. Chang,et al. ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis , 2021, Nature Genetics.
[3] Howard Y. Chang,et al. ArchR: An integrative and scalable software package for single-cell chromatin accessibility analysis , 2020, bioRxiv.
[4] Ryan M. Layer,et al. Regulatory sharing between estrogen receptor α bound enhancers , 2020, bioRxiv.
[5] Zhuqiang Zhang,et al. Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells , 2020, Genome Biology.
[6] Nuno A. Fonseca,et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes , 2020, Nature.
[7] Jun Yu,et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes , 2020, Nature.
[8] Takafumi N. Yamaguchi,et al. Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors. , 2019, Cancer cell.
[9] M. Beato,et al. C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells , 2019, The EMBO journal.
[10] C. Coarfa,et al. The genomic landscape of estrogen receptor α binding sites in mouse mammary gland , 2019, PloS one.
[11] J. Carroll,et al. Comprehensive Genomic Analysis Reveals that the Pioneering Function of FOXA1 Is Independent of Hormonal Signaling , 2019, Cell reports.
[12] Sreejith J. Nair,et al. Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly , 2019, Nature Structural & Molecular Biology.
[13] Nicola J. Rinaldi,et al. An AR-ERG transcriptional signature defined by long-range chromatin interactomes in prostate cancer cells , 2019, Genome research.
[14] P. Kantoff,et al. Low Expression of the Androgen-Induced Tumor Suppressor Gene PLZF and Lethal Prostate Cancer , 2019, Cancer Epidemiology, Biomarkers & Prevention.
[15] H. G. van der Poel,et al. Optimized ChIP-seq method facilitates transcription factor profiling in human tumors , 2018, Life Science Alliance.
[16] Luca Pinello,et al. CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data , 2018, bioRxiv.
[17] Jun Sese,et al. ChIP‐Atlas: a data‐mining suite powered by full integration of public ChIP‐seq data , 2018, EMBO reports.
[18] L. Wessels,et al. Integrative epigenetic taxonomy of primary prostate cancer , 2018, Nature Communications.
[19] Joshua M. Stuart,et al. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer , 2018, Cell.
[20] Andrew C. Adey,et al. Cicero Predicts cis-Regulatory DNA Interactions from Single-Cell Chromatin Accessibility Data. , 2018, Molecular cell.
[21] Joshua M. Stuart,et al. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer , 2018, Cell.
[22] Christopher W. Whelan,et al. Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing , 2018, Cell.
[23] Henry W. Long,et al. A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer , 2018, Cell.
[24] Yi Mi Wu,et al. The long tail of oncogenic drivers in prostate cancer , 2018, Nature Genetics.
[25] L. Wessels,et al. Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis , 2018, Oncogene.
[26] Łukasz M. Boryń,et al. Resolving systematic errors in widely-used enhancer activity assays in human cells , 2017, Nature Methods.
[27] A. Gursoy,et al. Androgen receptor binding sites are highly mutated in prostate cancer , 2017, bioRxiv.
[28] K. White,et al. Functional assessment of human enhancer activities using whole-genome STARR-sequencing , 2017, Genome Biology.
[29] William J. Greenleaf,et al. chromVAR: Inferring transcription factor-associated accessibility from single-cell epigenomic data , 2017, Nature Methods.
[30] Icgc,et al. Pan-cancer analysis of whole genomes , 2017, bioRxiv.
[31] André F. Rendeiro,et al. Functional Dissection of the Enhancer Repertoire in Human Embryonic Stem Cells , 2017, bioRxiv.
[32] S. Q. Xie,et al. Complex multi-enhancer contacts captured by Genome Architecture Mapping (GAM) , 2017, Nature.
[33] E. Niskanen,et al. Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-κB cistrome to reprogram the prostate cancer cell transcriptome , 2016, Nucleic acids research.
[34] C. Cordon-Cardo,et al. The role of GATA2 in lethal prostate cancer aggressiveness , 2017, Nature Reviews Urology.
[35] T. Mikkelsen,et al. Genome-scale high-resolution mapping of activating and repressive nucleotides in regulatory regions , 2016, Nature Biotechnology.
[36] Ian C. McDowell,et al. Direct GR Binding Sites Potentiate Clusters of TF Binding across the Human Genome , 2016, Cell.
[37] Nicholas A. Sinnott-Armstrong,et al. Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer , 2016, Nature Genetics.
[38] Michael T. McManus,et al. A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity , 2016, bioRxiv.
[39] Richard Bonneau,et al. Active and Inactive Enhancers Cooperate to Exert Localized and Long-Range Control of Gene Regulation. , 2016, Cell reports.
[40] Fidel Ramírez,et al. deepTools2: a next generation web server for deep-sequencing data analysis , 2016, Nucleic Acids Res..
[41] Klaus Hansen,et al. An interactive environment for agile analysis and visualization of ChIP-sequencing data , 2016, Nature Structural &Molecular Biology.
[42] Danai Koutra,et al. DeltaCon: Principled Massive-Graph Similarity Function with Attribution , 2016, ACM Trans. Knowl. Discov. Data.
[43] B. Lenhard,et al. GenomicInteractions: An R/Bioconductor package for manipulating and investigating chromatin interaction data , 2015, BMC Genomics.
[44] Steven J. M. Jones,et al. The Molecular Taxonomy of Primary Prostate Cancer , 2015, Cell.
[45] Henry W. Long,et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis , 2015, Nature Genetics.
[46] David C. Smith,et al. Integrative Clinical Genomics of Advanced Prostate Cancer , 2015, Cell.
[47] P. Kantoff,et al. PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy. , 2015, Cancer research.
[48] Lawrence D. True,et al. Integrative Clinical Genomics of Advanced Prostate Cancer , 2015, Cell.
[49] P. Unger,et al. Loss of PLZF Expression in Prostate Cancer by Immunohistochemistry Correlates with Tumor Aggressiveness and Metastasis , 2015, PloS one.
[50] Michael Q. Zhang,et al. Integrative analysis of 111 reference human epigenomes , 2015, Nature.
[51] O. Jänne,et al. SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin , 2014, Nucleic acids research.
[52] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[53] A. Quinlan. BEDTools: The Swiss‐Army Tool for Genome Feature Analysis , 2014, Current protocols in bioinformatics.
[54] K. Tan,et al. Global view of enhancer–promoter interactome in human cells , 2014, Proceedings of the National Academy of Sciences.
[55] P. Kantoff,et al. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation , 2014, Proceedings of the National Academy of Sciences.
[56] T. Meehan,et al. An atlas of active enhancers across human cell types and tissues , 2014, Nature.
[57] Simon G. Coetzee,et al. Comprehensive Functional Annotation of 77 Prostate Cancer Risk Loci , 2014, PLoS genetics.
[58] S. Vowler,et al. Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype , 2013, Oncogene.
[59] J. Li,et al. PLZF Mediates the PTEN/AKT/FOXO3a Signaling in Suppression of Prostate Tumorigenesis , 2013, PloS one.
[60] Yan Li,et al. A high-resolution map of three-dimensional chromatin interactome in human cells , 2013, Nature.
[61] Luke A. Gilbert,et al. CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.
[62] David A. Orlando,et al. Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.
[63] Łukasz M. Boryń,et al. Genome-Wide Quantitative Enhancer Activity Maps Identified by STARR-seq , 2013, Science.
[64] I. Mills,et al. The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man. , 2013, Cancer cell.
[65] Nathan C. Sheffield,et al. Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity , 2012, Genome Biology.
[66] Jun S. Song,et al. Statistical Applications in Genetics and Molecular Biology Normalization , bias correction , and peak calling for ChIP-seq , 2012 .
[67] C. Lo,et al. Shrimp Pm-fortilin inhibits the expression of early and late genes of white spot syndrome virus (WSSV) in an insect cell model. , 2011, Developmental and comparative immunology.
[68] Pedro M. Valero-Mora,et al. ggplot2: Elegant Graphics for Data Analysis , 2010 .
[69] Galt P. Barber,et al. BigWig and BigBed: enabling browsing of large distributed datasets , 2010, Bioinform..
[70] C. Glass,et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.
[71] Zhaohui S. Qin,et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. , 2010, Cancer cell.
[72] Clifford A. Meyer,et al. Nucleosome Dynamics Define Transcriptional Enhancers , 2010, Nature Genetics.
[73] Aaron R. Quinlan,et al. Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .
[74] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[75] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[76] H. Scher,et al. Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer , 2009, Science.
[77] V. Mladenova,et al. Organization of Plasmid DNA into Nucleosome-Like Structures after Transfection in Eukaryotic Cells , 2009 .
[78] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[79] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[80] Z. Weng,et al. High-Resolution Mapping and Characterization of Open Chromatin across the Genome , 2008, Cell.
[81] K. Pienta,et al. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. , 2007, Molecular cell.
[82] Nathaniel D. Heintzman,et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.
[83] Zhou Wang,et al. Identification and characterization of PLZF as a prostatic androgen‐responsive gene , 2004, The Prostate.
[84] C. Heinlein,et al. Androgen receptor in prostate cancer. , 2004, Endocrine reviews.
[85] D. Hartl,et al. Genetic applications of an inverse polymerase chain reaction. , 1988, Genetics.
[86] J. Banerji,et al. Expression of a β-globin gene is enhanced by remote SV40 DNA sequences , 1981, Cell.
[87] J. Banerji,et al. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. , 1981, Cell.